<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50425">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02107729</url>
  </required_header>
  <id_info>
    <org_study_id>2013/2297B</org_study_id>
    <nct_id>NCT02107729</nct_id>
  </id_info>
  <brief_title>The Importance of Needle Gauge for Pain During Injection of Local Anaesthetic.</brief_title>
  <official_title>The Importance of Needle Gauge for Pain During Injection of Local Anaesthetic.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <authority>Norway:National Committee for Medical and Health Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the influence of needle gauge on pain during injection of local
      anaesthetic. Healthy volunteers will be recruited, who will each receive three injections
      with either 21G, 23G or 27G subcutaneously on the abdomen. After each injection, the
      participants will be asked to evaluate the pain on a Visual analog scale (0-100 mm). It is
      anticipated that the pain will decrease with decreasing thickness of the needle. The aim of
      this study is to find a simple method for pain reduction that can be used in clinical
      practice.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>60 seconds</time_frame>
    <safety_issue>No</safety_issue>
    <description>Visual analog scale
Questionnaire</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Needlestick Injuries</condition>
  <arm_group>
    <arm_group_label>Needle gauge</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>each participant receives three lidocaine injections with different needle gauge</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Large needle gauge lidocaine injection</intervention_name>
    <description>21 G</description>
    <arm_group_label>Needle gauge</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Normal needle gauge lidocaine injection</intervention_name>
    <description>23 G</description>
    <arm_group_label>Needle gauge</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Small needle gauge lidocaine injection</intervention_name>
    <description>27 G</description>
    <arm_group_label>Needle gauge</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-65 years

        Exclusion Criteria:

          -  Kidney, heart or liver disease

          -  Eczema or psoriasis on injection site

          -  Neuropathy

          -  Regular use of painkillers

          -  Hypersensitivity of Lidocaine

          -  Pregnancy

          -  Diabetes
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vilhjalmur Finsen, Prof md</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neuroscience, NTNU</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 8, 2014</lastchanged_date>
  <firstreceived_date>April 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Injections</keyword>
  <keyword>Pain</keyword>
  <keyword>Healthy volunteers</keyword>
  <keyword>Lidocaine</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Needlestick Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
